XML 190 R174.htm IDEA: XBRL DOCUMENT
v3.21.2

Restatement of Previously Issued Financial Statements (Tables) | 7 Months Ended
--- | ---
Dec. 31, 2020
CIK0001816090 FTAC Olympus Acquisition Corp. |
Schedule of the restatement on each financial statement |
|  | As |  |  |  |  |  |  |
|  | Previously |  |  |  |  |  | As |
|  | Reported |  |  | Adjustments |  |  | Restated |
Balance sheet as of August 28, 2020 (audited) |  |  |  |  |  |  |  |  |
Warrant Liabilities |  | $ | - |  |  | $ | 42,957,966 |  |  | $ | 42,957,966 |
Total Liabilities |  |  | 30,038,556 |  |  |  | 42,957,966 |  |  |  | 72,996,522 |
Class A Ordinary Shares Subject to Possible Redemption |  |  | 721,047,750 |  |  |  | (42,957,966 | ) |  |  | 678,089,784 |
Class A Ordinary Shares |  |  | 507 |  |  |  | 429 |  |  |  | 936 |
Additional Paid-in Capital |  |  | 5,002,305 |  |  |  | 2,540,939 |  |  |  | 7,543,244 |
Accumulated Deficit |  |  | (5,015 | ) |  |  | (2,541,368 | ) |  |  | (2,546,383 | )
Shareholders’ Equity |  |  | 5,000,008 |  |  |  | - |  |  |  | 5,000,008 |
Number of shares subject to redemption |  |  | 72,104,775 |  |  |  | (4,295,797 | ) |  |  | 67,808,978 |
Balance sheet as of September 30, 2020 (unaudited) |  |  |  |  |  |  |  |  |  |  |  |
Warrant Liabilities |  | $ | - |  |  | $ | 43,739,664 |  |  | $ | 43,739,664 |
Total Liabilities |  |  | 30,306,708 |  |  | $ | 43,739,664 |  |  |  | 74,046,372 |
Class A Ordinary Shares Subject to Possible Redemption |  |  | 725,421,970 |  |  |  | (43,739,664 | ) |  |  | 681,682,306 |
Class A Ordinary Shares |  |  | 510 |  |  |  | 437 |  |  |  | 947 |
Additional Paid-in Capital |  |  | 5,087,486 |  |  |  | (3,058,560 | ) |  |  | 8,146,046 |
Accumulated Deficit |  |  | (89,928 | ) |  |  | (3,058,997 | ) |  |  | (3,148,925 | )
Shareholders’ Equity |  |  | 5,000,009 |  |  |  | - |  |  |  | 5,000,009 |
Number of shares subject to redemption |  |  | 72,542,197 |  |  |  | (4,373,966 | ) |  |  | 68,168,231 |
Balance sheet as of December 31, 2020 (audited) |  |  |  |  |  |  |  |  |  |  |  |
Warrant Liabilities |  | $ | - |  |  | $ | 49,174,771 |  |  | $ | 49,174,771 |
Total Liabilities |  |  | 30,404,648 |  |  |  | 49,174,771 |  |  |  | 79,579,419 |
Class A Ordinary Shares Subject to Possible Redemption |  |  | 724,852,470 |  |  |  | (49,174,771 | ) |  |  | 675,677,699 |
Class A Ordinary Shares |  |  | 516 |  |  |  | 492 |  |  |  | 1,008 |
Additional Paid-in Capital |  |  | 5,656,980 |  |  |  | 8,493,612 |  |  |  | 14,150,592 |
Accumulated Deficit |  |  | (659,436 | ) |  |  | (8,494,104 | ) |  |  | (9,153,540 | )
Shareholders’ Equity |  |  | 5,000,001 |  |  |  | - |  |  |  | 5,000,001 |
Number of shares subject to redemption |  |  | 72,485,247 |  |  |  | (4,917,477 | ) |  |  | 67,567,770 |
Three Months Ended September 30, 2020 (unaudited) |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of warrant liabilities |  |  | - |  |  |  | (517,629 | ) |  |  | (517,629 | )
Offering costs associated with warrants recorded as liabilities |  |  | - |  |  |  | (2,541,368 | ) |  |  | (2,541,368 | )
Net loss |  |  | (84,913 | ) |  |  | (3,058,997 | ) |  |  | (3,143,910 | )
Weighted average shares outstanding of Class A redeemable ordinary shares |  |  | 75,115,000 |  |  |  | - |  |  |  | 75,115,000 |
Basic and diluted net loss per share, Class A redeemable ordinary shares |  |  | 0.00 |  |  |  | 0.00 |  |  |  | 0.00 |
Weighted average shares outstanding of Class A and B non-redeemable ordinary shares |  |  | 20,089,849 |  |  |  | - |  |  |  | 20,089,849 |
Basic and diluted net loss per share, Class A and Class B non-redeemable ordinary shares |  |  | (0.00 | ) |  |  | (0.16 | ) |  |  | (0.16 | )
Period from June 2, 2020 (inception) to September 30, 2020 (unaudited) |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of warrant liabilities |  |  | - |  |  |  | (517,629 | ) |  |  | (517,629 | )
Offering costs associated with warrants recorded as liabilities |  |  | - |  |  |  | (2,541,368 | ) |  |  | (2,541,368 | )
Net loss |  |  | (89,928 | ) |  |  | (3,058,997 | ) |  |  | (3,148,925 | )
Weighted average shares outstanding of Class A redeemable ordinary shares |  |  | 75,115,000 |  |  |  | - |  |  |  | 75,115,000 |
Basic and diluted net loss per share, Class A redeemable ordinary shares |  |  | 0.00 |  |  |  | 0.00 |  |  |  | 0.00 |
Weighted average shares outstanding of Class A and B non-redeemable ordinary shares |  |  | 19,897,156 |  |  |  | - |  |  |  | 19,897,156 |
Basic and diluted net loss per share, Class A and Class B non-redeemable ordinary shares |  |  | (0.00 | ) |  |  | (0.16 | ) |  |  | (0.16 | )
Period from June 2, 2020 (inception) to December 31, 2020 (audited) |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of warrant liabilities |  |  | - |  |  |  | (5,952,736 | ) |  |  | (5,952,736 | )
Offering costs associated with warrants recorded as liabilities |  |  | - |  |  |  | (2,541,368 | ) |  |  | (2,541,368 | )
Net loss |  |  | (659,436 | ) |  |  | (8,494,104 | ) |  |  | (9,153,540 | )
Weighted average shares outstanding of Class A redeemable ordinary shares |  |  | 75,376,489 |  |  |  | - |  |  |  | 75,376,489 |
Basic and diluted net loss per share, Class A redeemable ordinary shares |  |  | 0.00 |  |  |  | 0.00 |  |  |  | 0.00 |
Weighted average shares outstanding of Class A and B non-redeemable ordinary shares |  |  | 20,766,410 |  |  |  | - |  |  |  | 20,766,410 |
Basic and diluted net loss per share, Class A and Class B non-redeemable ordinary shares |  |  | (0.03 | ) |  |  | (0.41 | ) |  |  | (0.44 | )
Cash Flow Statement for the period ended September 30, 2020 (unaudited) |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  | (89,928 | ) |  |  | (3,058,997 | ) |  |  | (3,148,925 | )
Change in fair value of warrant liabilities |  |  | - |  |  |  | 517,629 |  |  |  | 517,629 |
Transaction costs allocable to warrant liabilities |  |  | - |  |  |  | 2,541,368 |  |  |  | 2,541,368 |
Initial value of Class A ordinary shares subject to possible redemption |  |  | 725,506,890 |  |  |  | (43,222,035 | ) |  |  | 682,284,855 |
Change in value of Class A ordinary shares subject to possible redemption |  |  | (84,920 | ) |  |  | - |  |  |  | (84,920 | )
Cash Flow Statement for the period ended December 31, 2020 (audited) |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  | (659,436 | ) |  |  | (8,494,104 | ) |  |  | (9,153,540 | )
Change in fair value of warrant liabilities |  |  | - |  |  |  | 5,952,736 |  |  |  | 5,952,736 |
Transaction costs allocable to warrant liabilities |  |  | - |  |  |  | 2,541,368 |  |  |  | 2,541,368 |
Initial value of Class A ordinary shares subject to possible redemption |  |  | 725,506,890 |  |  |  | (43,222,035 | ) |  |  | 682,284,855 |
Change in value of Class A ordinary shares subject to possible redemption |  |  | (654,420 | ) |  |  | (5,952,736 | ) |  |  | (6,607,156 | )

X
- Definition Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedFinancialStatementsTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=payo_CIK0001816090FTACOlympusAcquisitionCorp.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |